|
|
 |
|
FRX: Forest Labs Inc - Stock News |
Enter Ticker:
|
|
| Nov 12, 2009 |
CL, EJ, GME, HSY, CNW and FRX Free Research report onBenchmarkJournal.com |
| Nov 09, 2009 |
Wedgewood Pharmacy Compounds Armour Thyroid Tablets Due to Shortages |
| Nov 03, 2009 |
Forest Laboratories (FRX) NewsBite - FRX Rises on Study Results |
| Nov 03, 2009 |
AnalystChoice.com Provides Analytical Coverage on XOM, SCG, FRX, WL,AVB and HXL |
| Nov 02, 2009 |
Forest Laboratories and Gedeon Richter Report Phase IIb Study Results of Cariprazine for the Treatment of Schizophrenia |
| Nov 02, 2009 |
Ironwood and Forest Announce Positive Linaclotide Results from Two Pivotal Phase 3 Trials in Patients with Chronic Constipation |
| Nov 02, 2009 |
ValuEngine Upgrades Forest Laboratories To aEUR~5' Rating |
| Oct 28, 2009 |
Forest Laboratories, Inc. and Gedeon Richter Announce Positive Results from a Phase IIb Study of Cariprazine for the Treatment of Schizophrenia |
| Oct 28, 2009 |
Sun Pharma to cease manufacturing generic Alzheimer's drug |
| Oct 28, 2009 |
ValuEngine Upgrades Forest Laboratories To aEUR~5' Rating |
| Oct 27, 2009 |
Zacks Analyst Blog Highlights: Theravance, ViroPharma, Pfizer, Johnson & Johnson and Forest Laboratories |
| Oct 21, 2009 |
Zacks Analyst Blog Highlights: Biogen Idec, Elan, UnitedHealth Group Inc., Forest Laboratories, Inc. and Cypress Biosciences |
| Oct 21, 2009 |
Forest Laboratories (FRX) Upgrade Alert, Watch for 31.3% Technical Uptrend Continuation |
| Oct 21, 2009 |
Analyst Upgrades for October 21st |
| Oct 20, 2009 |
BiomedReports: News and FDA Updates for Roche (OTC:RHHBY), Biogen Idec (Nasdaq:BIIB), Forest Labs (NYSE:FRX) Cypress BioscienceF (NASDAQ:CYPB) |
| |
| ZACKS COMMENTARY FOR FRX |
| Nov 18, 2009 | Zacks Blog: MDVN Starts New Alzheimer’s Trials | | Nov 16, 2009 | Zacks Equity Research: Report for FRX | | Nov 13, 2009 | Zacks Blog: AstraZeneca Beats, Raises | | Nov 11, 2009 | Zacks Blog: Cypress Beats, but Loss Widens | | Oct 27, 2009 | Zacks Blog: Zacks Analyst Blog Highlights: Theravance, ViroPharma, Pfizer, Johnson & Johnson and Forest Laboratories | | Oct 26, 2009 | Zacks Blog: Theravance Earns Milestone Payment | | Oct 21, 2009 | Zacks Blog: Zacks Analyst Blog Highlights: Biogen Idec, Elan, UnitedHealth Group Inc., Forest Laboratories, Inc. and Cypress Biosciences | | Oct 20, 2009 | Zacks Blog: Forest Reports In-Line | | Oct 09, 2009 | Zacks Blog: Novartis Acquires Antibiotic Rights | | Sep 14, 2009 | Zacks Blog: FRX Presents Encouraging Data | | Sep 01, 2009 | Zacks Blog: J&J Responds to FDA | | Aug 28, 2009 | Zacks Blog: Daxas Shows Promise |
|
|
Sponsored Links 
0.46